t. 647-964-9600

 

COVID-19 pandemic’s effect on cancer patients treatment

Posted Apr 1st, 2020 in Posts

COVID-19 pandemic’s effect on cancer patients treatment

CAMO conducted an on-line national survey from March to April among Medical Oncologists to better understand the implications of coronavirus on cancer care.  Questions covered important issues surrounding demographics, COVID-19 risk, personal protective equipment usage, personal challenges and chemotherapy management. 

Among the results, over 30% reported no routine use of PPE in clinical practices. Over 70% of oncologists were concerned that a patient would be COVID-19 from them.  70% weren’t sure if they would have adequate PPE access at work over the course of the pandemic.  

Additionally, 64% of physicians cancelled follow-ups for cancer patients.  54% completely stopped accruing new patients to clinical trials at their centers. Nearly 60% expressed moderate to high concern that patients would not receive sufficient care if they became seriously ill from a non-COVID illness.

During presentation of results, it was summarized that much is to be learned about alternate methods of care delivery – such as telemedicine – that will change practice under normal conditions.

find out if blueguide can help.

During your first contact with blueguide, we'll determine if we can help you. There is no risk, and no obligation. Just people who care.

learn more